FCS Press Releases

Lucio Gordan, MD, President & Managing Physician of Florida Cancer Specialists & Research Institute, LLC (FCS), talked with Kevin Keegan, General Manager of Oncology Business with Illumina, about how FCS is bringing precision oncology through analysis of real-world data, innovative technology and research to cancer patients being treated in community settings.

Drug shortages are a common issue in the health care industry. Florida Cancer Specialists & Research Institute (FCS) is highly skilled at proactively managing the drug supplies it needs to care for patients. However, a recent shortage of two critical chemotherapy drugs is impacting the lives of cancer patients and forcing oncologists to find alternative treatment options that are often less effective.

Florida Cancer Specialists & Research Institute, LLC (FCS) has introduced a new technology that provides multiple benefits for cancer patients receiving radiation therapy at the FCS Ocala Cancer Center, the first and only comprehensive cancer center in Marion County.

Florida Cancer Specialists & Research Institute, LLC (FCS) President & Managing Physician Lucio N. Gordan, MD, will join an expert panel of precision medicine leaders in Chicago this weekend to discuss the impact of genomic profiling.

Florida Cancer Specialists & Research Institute, LLC (FCS) physicians are presenting the outcomes of 23 clinical trials, the majority being Phase 1, at the 2023 American Society of Clinical Oncology (ASCO®) Annual Meeting on June 2 – 6 in Chicago, Illinois.

A collaborative effort of Florida Cancer Specialists & Research Institute, LLC (FCS) and CVS Health/Aetna to integrate cancer care advancements within a value-driven framework is delivering improved quality and cost savings for Medicare patients enrolled in the insurer’s Oncology Medical Home Program.

Florida Cancer Specialists & Research Institute, LLC (FCS) has named Wilfredo Blasini, MD as Medical Director of the Central Pathology Laboratory. Dr. Blasini will provide clinical leadership and oversight for the centralized laboratory which serves the practice’s nearly 100 locations statewide with a comprehensive testing menu, including advanced next-generation sequencing (NGS). Dr. Blasini joined FCS in 2012 as a hematopathologist and has served as co-director of the Pathology Laboratory since 2018.

Florida Cancer Specialists & Research Institute, LLC (FCS) is demanding reform in the pricing regulation of generic drugs, an issue that has deeply affected the oncology community for years but has worsened in recent months. Inadequacies in regulating average selling prices (ASP) for regimens crucial to patient care are directly affecting manufacturers’ ability to maintain operations and productivity for critical generic drugs.

A known leader in value-based oncology care, Florida Cancer Specialists & Research Institute, LLC (FCS) continues to forge new partnerships with alternative payment models and payers. The statewide community oncology practice with nearly 100 locations was a top performer in the Centers for Medicare and Medicaid Innovation’s (CMMI) pilot value-based oncology care program, the Oncology Care Model (OCM), which ended in 2022.

Florida Cancer Specialists & Research Institute, LLC (FCS) President & Managing Physician Lucio Gordan, MD is among the national experts and physician leaders at the ION Exchange 2023 this week in San Diego who will share the latest clinical, operational and business insights to advance the quality of cancer care in community settings.

Florida Cancer Specialists & Research Institute, LLC (FCS) celebrated the opening of its new clinic location in Clermont with a ribbon-cutting ceremony on Thursday, April 27, 2023. The new facility at 1340 N. Hancock Road, Clermont, FL 34711 replaces the former location in Lake County.

Florida Cancer Specialists & Research Institute, LLC (FCS) is pleased to welcome two Board-certified medical oncologists to its Delray clinic in Palm Beach County. Elena Kruglyak, MD and Samarth L. Reddy, MD have joined the statewide practice, and are providing care to patients at 5130 Linton Blvd, Suite B4, Delray Beach, Florida 33484.

Florida Cancer Specialists and Research Institute participation in clinical trials leads to FDA approval of polatuzumab vedotin.

A panel of multidisciplinary experts have reviewed previous American Society of Clinical Oncology (ASCO) guidelines for treating anxiety and depression in adult cancer survivors. The Practice Guidelines Implementation Network (PGIN) committee, which includes Florida Cancer Specialists & Research Institute, LLC (FCS) medical oncologist Barry Berman, MD, MS, released updates to the pre-existing guidelines last revised in 2014 in the abstract: “Management of Anxiety and Depression in Adult Survivors of Cancer: ASCO Guideline Update.”

Florida Cancer Specialists & Research Institute, LLC (FCS) medical oncologist Richard McDonough, MD, is the recipient of the Florida Society of Clinical Oncology (FLASCO) 2023 Dorothy Green Phillips Legacy Award. The recognition was announced at FLASCO’s Annual Gala held on April 14 in Orlando.